Orizuru Therapeutics, Inc.

About Orizuru Therapeutics, Inc.

The startup develops cell-related therapeutics utilizing induced pluripotent stem cells through cardiomyocyte differentiation and myocardial purification methods with small-molecule compounds. This research enables pre-clinical validation for improved regenerative medicine treatments and cell transplantation procedures.

What does Orizuru Therapeutics, Inc. do?

The startup develops cell-related therapeutics utilizing induced pluripotent stem cells through cardiomyocyte differentiation and myocardial purification methods with small-molecule compounds. This research enables pre-clinical validation for improved regenerative medicine treatments and cell transplantation procedures.

Where is Orizuru Therapeutics, Inc. located?

Orizuru Therapeutics, Inc. is based in Fujisawa, Japan.

When was Orizuru Therapeutics, Inc. founded?

Orizuru Therapeutics, Inc. was founded in 2021.

How much funding has Orizuru Therapeutics, Inc. raised?

Orizuru Therapeutics, Inc. has raised 90180000.

Location
Fujisawa, Japan
Founded
2021
Funding
90180000
Employees
13 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Orizuru Therapeutics, Inc.

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

The startup develops cell-related therapeutics utilizing induced pluripotent stem cells through cardiomyocyte differentiation and myocardial purification methods with small-molecule compounds. This research enables pre-clinical validation for improved regenerative medicine treatments and cell transplantation procedures.

orizuru-therapeutics.com100+
Founded 2021Fujisawa, Japan

Funding

$

Estimated Funding

$50M+

Team (10+)

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.